CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD
CSMN
CSMN was delisted on the 16th of April, 2015.
2 hedge funds and large institutions have $1.93M invested in CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
2% more capital invested
Capital invested by funds: $1.9M → $1.93M (+$29K)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
33% less funds holding
Funds holding: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$94.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11K |
CSMN Hedge Fund Activity: Q4 2014 in Review
2 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD (CSMN) for Q4 2014, worth a combined $1.93M — up 1.5% from $1.9M a quarter earlier.
Fund positioning in CSMN was balanced in Q4 2014: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Credit Suisse, adding an estimated $94.7K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $11K sold.
- 2 institutional investors held CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD (CSMN) as of Q4 2014, down from 3 in Q3 2014.
- Funds reported $1.93M of CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD stock for Q4 2014, up 1.5% quarter-over-quarter.
- 1 fund opened new CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD positions in Q4 2014 and 1 closed out, a net change of 0 holders.
- The largest CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD buyer in Q4 2014 was Credit Suisse, an estimated $94.7K added.
- The largest CREDIT SUISSE NASSAU BRH EQUITY MARKET NEUTRAL ETN LKD seller in Q4 2014 was Tower Research Capital (TRC), an estimated $11K sold.
Based on aggregated 13F filings for Q4 2014.